Literature DB >> 29523913

[Autoimmune encephalitis with psychotic symptoms : Diagnostics, warning signs and practical approach].

J Steiner1,2, H Prüß3,4, S Köhler5, A Hasan6, P Falkai6.   

Abstract

Despite intensive research, a precise cause of schizophrenic and schizoaffective disorders has not yet been identified. Therefore, psychiatric diagnoses are still made based on clinical ICD-10/DSM‑5 criteria and not on any objective markers; however, various causes or pathophysiological processes may ultimately lead to similar symptoms. An important task for the future of psychiatry is to identify disease subtypes with a distinct pathophysiology to develop more specific and causally acting therapies. A new diagnostic entity has become established in clinical neurology and psychiatry in recent years: autoimmune encephalitis with psychotic symptoms caused by specific antineuronal antibodies has been identified as a rare but potentially treatable cause of psychotic disorders; however, these inflammatory brain diseases are not reliably detected by routine psychiatric diagnostics. Therefore, this qualitative review is intended to provide structured support for clinical practice, which, guided by clinical warning signals, enables a rapid and reliable diagnosis as well as the initiation of immunotherapy. In the case of psychiatric symptoms, the additional onset of focal neurological signs, disturbances of consciousness and orientation, autonomic instability or epileptic seizures and electroencephalograph (EEG) abnormalities should always be followed by a more specific cerebrospinal fluid analysis with determination of antineuronal autoantibodies. Although the scientific evidence indicates that only a small subgroup of patients is affected, the swift and correct diagnosis is of high therapeutic and prognostic relevance for the affected individuals.

Entities:  

Keywords:  Antineuronal antibodies; Cerebrospinal fluid diagnostics; Limbic encephalitis; Psychosis; Schizophrenia

Mesh:

Substances:

Year:  2018        PMID: 29523913     DOI: 10.1007/s00115-018-0499-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  31 in total

1.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

2.  Cell- and Single Molecule-Based Methods to Detect Anti-N-Methyl-D-Aspartate Receptor Autoantibodies in Patients With First-Episode Psychosis From the OPTiMiSE Project.

Authors:  Julie Jézéquel; Véronique Rogemond; Thomas Pollak; Marilyn Lepleux; Leslie Jacobson; Hélène Gréa; Conrad Iyegbe; Rene Kahn; Philip McGuire; Angela Vincent; Jérôme Honnorat; Marion Leboyer; Laurent Groc
Journal:  Biol Psychiatry       Date:  2017-07-06       Impact factor: 13.382

Review 3.  Sustained corticosteroid- induced mania and psychosis despite cessation: A case study and brief literature review.

Authors:  Mary Gable; Dwayne Depry
Journal:  Int J Psychiatry Med       Date:  2015       Impact factor: 1.210

4.  Disease-relevant autoantibodies in first episode schizophrenia.

Authors:  Michael S Zandi; Sarosh R Irani; Bethan Lang; Patrick Waters; Peter B Jones; Peter McKenna; Alasdair J Coles; Angela Vincent; Belinda R Lennox
Journal:  J Neurol       Date:  2010-10-26       Impact factor: 4.849

5.  Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study.

Authors:  Yoshihito Ando; Haruo Shimazaki; Katsutoshi Shiota; Syuichi Tetsuka; Koichi Nakao; Tatsuhiro Shimada; Kazumi Kurata; Jinichi Kuroda; Akihiro Yamashita; Hayato Sato; Mamoru Sato; Shinkichi Eto; Yasunori Onishi; Keiko Tanaka; Satoshi Kato
Journal:  BMC Psychiatry       Date:  2016-07-08       Impact factor: 3.630

6.  Neuroleptic intolerance in patients with anti-NMDAR encephalitis.

Authors:  Florian Lejuste; Laure Thomas; Géraldine Picard; Virginie Desestret; François Ducray; Veronique Rogemond; Dimitri Psimaras; Jean-Christophe Antoine; Jean-Yves Delattre; Laurent Groc; Marion Leboyer; Jerome Honnorat
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-08-29

7.  Synaptic and Neuronal Autoantibody-Associated Psychiatric Syndromes: Controversies and Hypotheses.

Authors:  Adam Al-Diwani; Thomas A Pollak; Alexander E Langford; Belinda R Lennox
Journal:  Front Psychiatry       Date:  2017-02-06       Impact factor: 4.157

8.  Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients.

Authors:  Julia Herken; Harald Prüss
Journal:  Front Psychiatry       Date:  2017-02-16       Impact factor: 4.157

Review 9.  A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis.

Authors:  Souhel Najjar; Johann Steiner; Amanda Najjar; Karl Bechter
Journal:  J Neuroinflammation       Date:  2018-02-13       Impact factor: 8.322

10.  Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model.

Authors:  Hong Pan; Bárbara Oliveira; Gesine Saher; Ekrem Dere; Daniel Tapken; Marina Mitjans; Jan Seidel; Janina Wesolowski; Debia Wakhloo; Christina Klein-Schmidt; Anja Ronnenberg; Kerstin Schwabe; Ralf Trippe; Kerstin Mätz-Rensing; Stefan Berghoff; Yazeed Al-Krinawe; Henrik Martens; Martin Begemann; Winfried Stöcker; Franz-Josef Kaup; Reinhard Mischke; Susann Boretius; Klaus-Armin Nave; Joachim K Krauss; Michael Hollmann; Fred Lühder; Hannelore Ehrenreich
Journal:  Mol Psychiatry       Date:  2018-02-09       Impact factor: 15.992

View more
  6 in total

1.  [Autoantibody-associated schizophreniform psychoses: pathophysiology, diagnostics, and treatment].

Authors:  Ludger Tebartz van Elst; Karl Bechter; Harald Prüss; Alkomiet Hasan; Jo Hann Steiner; Frank Leypoldt; Dominique Endres
Journal:  Nervenarzt       Date:  2019-07       Impact factor: 1.214

Review 2.  [Poison in the filter: implementing detoxification procedures in schizophrenia].

Authors:  Ekkehardt Kumbier
Journal:  Nervenarzt       Date:  2019-11       Impact factor: 1.214

Review 3.  Systematic Review: Syndromes, Early Diagnosis, and Treatment in Autoimmune Encephalitis.

Authors:  Christina Hermetter; Franz Fazekas; Sonja Hochmeister
Journal:  Front Neurol       Date:  2018-09-05       Impact factor: 4.003

4.  Management of Autoimmune Encephalitis: An Observational Monocentric Study of 38 Patients.

Authors:  Stefan Macher; Friedrich Zimprich; Desiree De Simoni; Romana Höftberger; Paulus S Rommer
Journal:  Front Immunol       Date:  2018-11-22       Impact factor: 7.561

Review 5.  Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations.

Authors:  Dominique Endres; Frank Leypoldt; Karl Bechter; Alkomiet Hasan; Johann Steiner; Katharina Domschke; Klaus-Peter Wandinger; Peter Falkai; Volker Arolt; Oliver Stich; Sebastian Rauer; Harald Prüss; Ludger Tebartz van Elst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-03-12       Impact factor: 5.270

6.  Anti-NMDA receptor encephalitis and overlapping demyelinating disorder in a 20-year old female with borderline personality disorder: proposal of a diagnostic and therapeutic algorithm for autoimmune encephalitis in psychiatric patients "case report".

Authors:  David Weiss; Lisa Kertzscher; Magdalena Degering; David Wozniak; Michael Kluge
Journal:  BMC Psychiatry       Date:  2021-07-15       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.